Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Augmentation of Prolonged Exposure for PTSD
NCT03238924Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2015
- Primary completion
- Dec 2016
01
Overview
A Phase 2 trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD), sponsored by Medical University of South Carolina. Started Jan 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03238924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238924.